November 2007 - Volume 21 - Issue 17 - Contributor Index

Alphabetical Search
X

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

Author:
Ba, Madina

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Author:
Balkan, Suna

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

Ferradini, Laurent; Laureillard, Didier; Prak, Narom; More

AIDS . 21(17):2293-2301, November 2007.

Author:
Barin, Francis

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Author:
Barker, Edward
Author:
Berry, Mark
Author:
Brooks, Cicely

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Author:
Brunet, Sylvie

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults

Erikstrup, Christian; Kallestrup, Per; Zinyama-Gutsire, Rutendo B; More

AIDS . 21(17):2283-2291, November 2007.

Author:
Calvez, Vincent

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Author:
Caumo, Andrea

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Author:
Chen, Joshua

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, John M; Emery, Sean; Kelleher, Anthony D; More

AIDS . 21(17):2315-2321, November 2007.

Author:
Cooper, David A

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, John M; Emery, Sean; Kelleher, Anthony D; More

AIDS . 21(17):2315-2321, November 2007.

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Author:
Daudon, Michel
Author:
Dean, Gillian
Author:
Deeks, Steven

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

Ferradini, Laurent; Laureillard, Didier; Prak, Narom; More

AIDS . 21(17):2293-2301, November 2007.

Author:
Derache, Anne

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Author:
Detels, Roger

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Author:
Emery, Sean

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, John M; Emery, Sean; Kelleher, Anthony D; More

AIDS . 21(17):2315-2321, November 2007.

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults

Erikstrup, Christian; Kallestrup, Per; Zinyama-Gutsire, Rutendo B; More

AIDS . 21(17):2283-2291, November 2007.

Author:
Eron, Joseph J
Author:
Fast, Patricia

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

Ferradini, Laurent; Laureillard, Didier; Prak, Narom; More

AIDS . 21(17):2293-2301, November 2007.

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

Ferradini, Laurent; Laureillard, Didier; Prak, Narom; More

AIDS . 21(17):2293-2301, November 2007.

Author:
Fiscus, Susan A
Author:
Fisher, Martin
Author:
Foust, Evelyn
Author:
Galli, Laura

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

Author:
García, Rosa
Author:
Germano, Paola

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

Author:
Gerstoft, Jan

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults

Erikstrup, Christian; Kallestrup, Per; Zinyama-Gutsire, Rutendo B; More

AIDS . 21(17):2283-2291, November 2007.

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

Author:
Gomo, Exnevia

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults

Erikstrup, Christian; Kallestrup, Per; Zinyama-Gutsire, Rutendo B; More

AIDS . 21(17):2283-2291, November 2007.

Author:
Gouws, Eleanor

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Author:
Hazuda, Daria J

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, John M; Emery, Sean; Kelleher, Anthony D; More

AIDS . 21(17):2315-2321, November 2007.

Author:
Hillis, Susan
Author:
Homer, Gary
Author:
Hung, Yee Ping
Author:
Jain, Mamta K

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Author:
Kallestrup, Per

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults

Erikstrup, Christian; Kallestrup, Per; Zinyama-Gutsire, Rutendo B; More

AIDS . 21(17):2283-2291, November 2007.

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, John M; Emery, Sean; Kelleher, Anthony D; More

AIDS . 21(17):2315-2321, November 2007.

Author:
Koff, Wayne
Author:
Kramer, Susanne
Author:
Kuruc, JoAnn
Author:
Landay, Alan

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

Ferradini, Laurent; Laureillard, Didier; Prak, Narom; More

AIDS . 21(17):2293-2301, November 2007.

Author:
Law, Matthew

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, John M; Emery, Sean; Kelleher, Anthony D; More

AIDS . 21(17):2315-2321, November 2007.

Author:
Lawn, Stephen D
Author:
Leigh, Jennifer
Author:
Leone, Peter A
Author:
Lot, Florence

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006

Barin, Francis; Cazein, Françoise; Lot, Florence; More

AIDS . 21(17):2351-2353, November 2007.

Author:
Luzi, Livio
Author:
Ly, Nary

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

Ferradini, Laurent; Laureillard, Didier; Prak, Narom; More

AIDS . 21(17):2293-2301, November 2007.

Author:
Lynch, Allison
Author:
M'rad, Mona Ben

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention

Andreotti, Mauro; Guidotti, Giovanni; Galluzzo, Clementina M; More

AIDS . 21(17):2360-2362, November 2007.

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

Marcelin, Anne-Geneviève; Jarrousse, Bernard; Derache, Anne; More

AIDS . 21(17):2341-2343, November 2007.

Author:
Martinson, Jeff
Author:
Master, Viraj A
Author:
McCoy, Sandra I